AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia

Status Recruiting

Clinical Trial Summary

This project investigates intentionally hypotensive management such as NTG (nitroglycerin) or NTG+Trandate during general anesthesia in patients undergoing orthognathic surgery. Throughout the entire surgical procedure, blood biochemical and urine monitoring will be conducted. Serum creatinine (Cr) levels, urine analysis, and perioperative monitoring will be utilized as indicators for assessing renal function during the surgery. The objective is to assess its potential renal injury and identify early risk factors for acute kidney injury (AKI). Timely recognition of these factors will allow for the implementation of appropriate intervention strategies, aiding in the prevention of postoperative acute kidney injury. This approach contributes to achieving the goals of Enhanced Recovery After Surgery (ERAS) for surgical patients, promoting faster postoperative recovery.

Clinical Trial Description

Orthognathic surgery is currently a common procedure in oral and maxillofacial surgery. The facial region is composed of a complex and dense vascular network, requiring precise, accurate, and delicate surgical techniques on both hard and soft tissues. During intraoral procedures, the surgical field may be limited, making the management of surgical bleeding challenging. Controlled hypotension or hypotensive anesthesia is often employed during major maxillofacial surgeries to optimize conditions. Lowering blood pressure is advantageous as it helps reduce overall blood loss and improves the surgeon's visibility. Therefore, maintaining stable blood pressure within the ideal range during the surgical process is a critical anesthesia objective. This research emphasizes the prevention of acute kidney injury (AKI) in patients undergoing orthognathic surgery with intentional hypotension during general anesthesia. The goal is to detect the potential renal damage at an early stages, before a significant decline in kidney function occurs, thereby reducing the likelihood of acute kidney injury. ;

Study Design

Related Conditions & MeSH terms

Acute Kidney Injury
Acute Kidney Injury (Nontraumatic)
Hypotension
Hypotension Drug-Induced

Clinical Trial Details

NCT number	NCT06259760
Study type	Observational [Patient Registry]
Source	Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact	Kuang-I Cheng, Phd
Phone	886-7-3121101
Email	kuaich@gmail.com
Status	Recruiting
Phase
Start date	March 1, 2024
Completion date	December 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05970770` - Hypotension Prediction Index vs Norepinephrine Infusion for Prevention of Spinal Hypotension for Cesarean Delivery	Phase 4
Recruiting	`NCT03626454` - Norepinephrine Addition in Spinal Anesthesia of Caesarean Section	N/A
Completed	`NCT03834454` - Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population	N/A
Recruiting	`NCT05661942` - Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate	Phase 4
Recruiting	`NCT05079269` - Pre-op Fluid Study	N/A
Completed	`NCT02967029` - Effect of Controlled Hypotension on Cerebral Oxygen Saturation	Phase 4
Recruiting	`NCT06334549` - A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia	Phase 4
Not yet recruiting	`NCT03465943` - Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia	Early Phase 1
Not yet recruiting	`NCT03478618` - Comparison of Different Protocols of Fluid Therapy in Severe Preeclamptic Patients Under Spinal Anesthesia	Early Phase 1
Completed	`NCT05143684` - Maternal Lateral Tilt and Cardiac Output in Caesarean Section
Recruiting	`NCT03743870` - Spinal Anesthesia in Caesarean Section
Completed	`NCT02979405` - Effectiveness of Phenylefrine in Prevention of Hypotension During Spinal Anesthesia for Cesarean Delivery	Phase 4
Completed	`NCT05101291` - Fractional Spinal Anesthesia and Systemic Hemodynamics in Frail Elderly Hip Fracture Patients.	N/A
Recruiting	`NCT04914234` - Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries	Phase 4
Completed	`NCT05502146` - Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal Hypotension	Phase 4
Completed	`NCT05368376` - Is Labetalol More Effective Than Metoprolol for Controlled Hypotensive Anesthesia During Endoscopic Nasal Surgeries?	Phase 4
Completed	`NCT04865614` - Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.